Based on WHO 2021 classification and other previous reports has already established that Chr7 gain & Chr10 loss, TERT mutation along with EGFR expression and MGMT promoter methylation are the strongest predictor of survival in glioblastomas [25, 35, 39]. This evidence concerns the gene TERT and glioblastoma.